UK Cardiology Market: Global Industry Growth, Market Size, Share and Forecast 2019-2025

1. Orion Market Research UK Cardiology Market: Market Size, Industry Trends, Leading Players, Share & Forecast 2019-2025 For free sample request visit: https://www.omrglobal.com/request-sample/uk- cardiology-market Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

2. UK Cardiology Market: Market Size, Industry Trends, Leading Players, Share & Forecast 2019-2025 UK cardiology market is estimated to grow significantly at a CAGR of 6.4% during the forecast period. UK has the highest number of CVD, Congenital heart disease (CHD), stroke, heart failure, atrial fibrillation and other heart related disease that further contributing to the growth of the market. According to one of the reports published by the British Heart Foundation in 2017, more than one- fourth of the fatalities in UK are due to CVD, which is responsible for around 1.6 million fatalities each year. The above data reflects the mortalities recorded in England, Wales, Scotland and Northern Ireland. A total of 56,493 mortalities were recorded in England followed by 7,182 in Scotland. Similarly, Wales and Northern Ireland reported 4,082 and 1,825 deaths respectively. These numbers of mortalities and incidence of heart related diseases increase the demand for cardiology devices, drugs and surgeries that further propels the market growth. To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/uk-cardiology-market The market is segmented on the basis of Device type, drug type, mechanism, and surgeries type. Based on device type, the market is segregated angioplasty, cardiovascular stents, cardiovascular catheters, cardiac rhythm management, cardiovascular assistive devices. Angioplasty and vascular stenting are widely adopted procedures in the cardiology market and have a considerable market share. Based on the drug type, the market is segmented into antithrombotic drugs, antidyslipidemic drugs, antihypertensive drugs, and anti-stroke drugs. On the basis of surgeries type, the market is classified into coronary artery bypass grafting, transmyocardial laser revascularization, heart valve repair, arrhythmia treatment, aneurysm repair, and heart transplant. UK Cardiology Market-Segmentation

3. By Device Type Angioplasty Cardiovascular stents Cardiovascular catheters Cardiac rhythm management Cardiovascular assistive devices By Mechanism Antithrombotic drugs Antidyslipidemic drugs Antihypertensive drugs Anti-stroke drugs By Surgeries Type Beta blockers Beta agonists Alpha blockers Alpha agonists Sodium channel blockers Calcium channel blockers Vasodilators Renin inhibitors Angiotensin receptor blockers Diuretics Thrombolytics

4. By Drug Type Coronary artery bypass grafting Transmyocardial laser revascularization Heart valve repair Arrhythmia treatment Aneurysm repair Heart transplant A full report of UK Cardiology Market is available at: https://www.omrglobal.com/industry- reports/uk-cardiology-market Company Profiles Abbott Laboratories AstraZeneca PLC Bayer AG Boehringer Ingelheim International GmbH F. Hoffmann-La Roche AG General Electric Co. Medtronic PLC Merck KGaA Novartis International AG Sanofi S.A. For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/uk-cardiology-market Media Contact: Company Name: Orion Market Reports

5. Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404